Immunomodulatory effects of IFN-beta1a treatment alone or associated with pentoxifylline in patients with relapsing-remitting multiple sclerosis (RRMS).

Pede, P Di; Visintini, D; Telera, A; Cucurachi, L; Campanini, C; Immovilli, P; Vescovini, R; Sansoni, P

Pede, P Di; Visintini, D; Telera, A; Cucurachi, L; Campanini, C; Immovilli, P; Vescovini, R; Sansoni, P.

Affiliation

Pede PD; Dipartimento di Medicina Interna e Scienze Biomediche, University of Parma, 43100 Parma. Italy.

J Interferon Cytokine Res ; 25(8): 485-9, 2005 Aug.

Article in En | MEDLINE | ID: mdl-16108731

Subject(s)

Interferon-beta/administration & dosage; Interferon-beta/therapeutic use; Multiple Sclerosis, Relapsing-Remitting/drug therapy; Multiple Sclerosis, Relapsing-Remitting/immunology; Pentoxifylline/administration & dosage; Pentoxifylline/therapeutic use; Cells, Cultured; Female; Humans; Interferon-gamma/metabolism; Interleukin-10/metabolism; Interleukin-2/metabolism; Male; Multiple Sclerosis, Relapsing-Remitting/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Interferon-beta / Multiple Sclerosis, Relapsing-Remitting Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Interferon Cytokine Res Year: 2005 Document type: Article

Search on Google

XML

PubMed Links